- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Persistence with Denosumab in Women at High Risk of Fracture in Bulgaria ; day:8 ; month:2 ; year:2021 ; pages:1-13
Rheumatology and therapy ; (8.2.2021), 1-13
- Urheber
-
Monov, Simeon
Nestorova, Rodina
Velkova, Margarita
Boyanov, Mihail
Jeleva, Silvia
Petkova, Renata
Petranova, Tzvetanka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-021-00282-3
- URN
-
urn:nbn:de:101:1-2021030321103845831523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Monov, Simeon
- Nestorova, Rodina
- Velkova, Margarita
- Boyanov, Mihail
- Jeleva, Silvia
- Petkova, Renata
- Petranova, Tzvetanka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Denosumab and muscle performance
Denosumab: A comprehensive review
Long-term persistence of treatment after hip fracture in a fracture liaison service
The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study
Bulgaria
Bułgaria
Bulgaria
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Denosumab and muscle performance
Denosumab: A comprehensive review
Long-term persistence of treatment after hip fracture in a fracture liaison service
The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study
Bulgaria
Bułgaria
Bulgaria
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Denosumab and muscle performance
Denosumab: A comprehensive review
Long-term persistence of treatment after hip fracture in a fracture liaison service
The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study
Bulgaria
Bułgaria